We aim to be the most efficient organization serving medical industry to enter China with our unparalleled expertise and global vision.
J MedTec is the set of four companies founded by several common shareholders to support US/EU medical technology companies to grow a solid business in China. J MedTec’s core competence include China strategy, China Regulatory and Clinical, China localization, China sales and distribution, and funding.
we also help China medical device companies acquire US/EU technologies and gain US/EU market access.
JMedTec provides NMPA regulatory and clinical services to medical device and pharmaceutical companies to gain China market access. J MedTec plays a key leading role among the portfolio companies to identify US/EU partners and technologies, and help US/EU companies’ China strategy, China business execution, and funding.
SumMed Capital is a VC fund focusing on the early stage investment for medical devices.
Ansheng Hangzhou is a medical device incubator and a medical device contract development and manufacturing organisation for innovative medical device products introduced into China by setting up partnership with overseas manufacturers.
Kai MedTech and its subsidiary in the US is a company to development innovative technology in neuro-intervention.
Chao Xu Ph.D, CEO of JMedTec, Venture Partner of SunMed Capital
Former General Manager, Osmunda Europe Expertise: R&D, China and EU Regulatory Affairs.
An Liu, CEO of Kai MedTech and Artisian MedTech,Venture Partner of SunMed Capital
Former General Manager of NAMSA APAC. Expertise: Global regulatory strategy, China business, device R&D platform.
Joshua Benjamin, VP R&D of Kai MedTech
Former R&D director in 4 startups sold to global corporations. Expertise: Research and Development
Michael Wang, General Partner of SunMed Capital
Former BioVenture Partner, Former R&D and BD director in Medtronic Expertise: Medical Device Investment